Development of Nonaggregating Poly-A Tailed Immunostimulatory A/D Type CpG Oligodeoxynucleotides Applicable for Clinical Use

Table 2

DLS measurement of each ODN in Figure 3.

	Diameter (nm)	% Pd	Mw-R (kDa)	% intensity	% mass
K3	2.7	26.0	7	100.0	100.0
D35	213.2	74.2	187014	77.1	79.7
D35-dAs40	11.8	48.7	212	97.2	99.9
D35T-dAs40	7.6	43.3	76	80.6	99.6
D35core-dAs40	6.9	23.5	61	96.6	100.0
D35coreT-dAs40	7.3	35.4	70	79.4	99.6

The value of the main peak in each ODN measurement is shown. Pd: polydispersity.